Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | |
| Sales | 3,040 | 0 |
| Gross Profit | 3,040 | N/A |
| Operating Expenses | 18,439 | 0 |
| Operating Income | -15,399 | N/A |
| Interest Expense | 552 | 0 |
| Other Income | 3,071 | 0 |
| Pre-tax Income | -12,880 | 0 |
| Net Income Continuous | -12,880 | N/A |
| Net Income | $-12,880 | $N/A |
| EPS Basic Total Ops | -235.44 | N/A |
| EPS Basic Continuous Ops | -184.98 | N/A |
| EPS Diluted Total Ops | -235.44 | N/A |
| EPS Diluted Continuous Ops | -184.98 | N/A |
| EBITDA(a) | $-14,535 | $N/A |